ALVAC-vCP125

N/A

Report date: 2022/02/14 17:41:54

Base Information

Drug NameALVAC-vCP125
Drug Alias NamevCP-125ALVAC vCP-125
ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsEnvelope glycoprotein gp160
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co IncSanofiVirogenetics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVirogeneticsSanofiMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A